retatrutide parkinson clinical trial ESC 2024: improves lipid and cardiovascular risk profile in Phase II Top Knee Osteoarthritis Clinical Trials

Compounded GLP-1s are produced in FDA-regulated facilities, but the medications themselves are not FDA-approved or reviewed by the FDA for safety, effectiveness, or quality before marketing

The FDA has continued to issue guidance on compounded GLP-1 medications and is reviewing further restrictions on large-scale outsourcing compounding of these drugs

Press release: Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy in a pill ) at ObesityWeek 2025, including demonstrated reductions in cardiovascular risk factors.* Retrieved from Rosenstock, J., Hsia, S., Ruiz, L

TRIUMPH3 includes a substudy to measure body composition via DXA in approximately 100 participants to assess percent and absolute change in total body fat and lean mass

PMC2956961

Determine if youre a good candidate for Sofwave Schedule a FREE Consultation